Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Close-field electroporation gene delivery for damaged cochlear hair cells regeneration

May 29, 2014

Novartis plans phase I/II study of CGF-166

May 15, 2014

Oricula Therapeutics receives NIH grant to further develop medicine to preserve hearing

May 2, 2014

Oricula Therapeutics secures intellectual property and funding to prevent hearing loss

April 10, 2014

Amarantus acquires option to license intellectual property for MANF and CDNF

March 10, 2014

Auris Medical enrolls first patient in European study of AM-101 in peripheral tinnitus

Feb. 25, 2014

Third milestone achieved in GenVec and Novartis collaboration

Feb. 17, 2014

Audion Therapeutics and Lilly to develop hearing loss treatments

Feb. 11, 2014

New potassium channel modulators patented by Autifony Therapeutics

Dec. 16, 2013

Otonomy's OTO-201 reduces treatment failure in subjects undergoing ear tube placement surgery

Aug. 21, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...